Efficacious Healing of Ulcerated Infantile Hemangiomas Using Topical Timolol

Summary: Infantile hemangiomas (IHs) are the most common benign pediatric soft-tissue tumors. Ulceration—the most frequent complication of IH—tends to heal poorly and is associated with pain, bleeding, infection, and scarring. Mainstay treatment modalities include propranolol (β-blocker) and corticosteroids, whose effectiveness is countered by a need for long-term medication and risk of systemic adverse effects and ulcer recurrence. A 3-month-old infant presented to us with a large, medial thigh-ulcerated IH that progressed despite 2 prior months of dressings and topical antimicrobials. Topical timolol 0.5% thrice daily was initiated, and significant healing was evident at 1 week, with complete healing at 1 month. Timolol was stopped after 3 months, and at 18 months after cessation of timolol, there was no ulcer recurrence. This novel therapy for ulcerated IH seems to have many advantages such as rapid efficacy with easy application, no systemic adverse effects and no long-term recurrence, and current literature describing similar advantages justifies the use of this treatment modality in infants.

[1]  M. Chu,et al.  Ulcerated Infantile Hemangioma: Novel Treatment with Topical Brimonidine‐Timolol , 2014, Pediatric dermatology.

[2]  Jayakar Thomas,et al.  Ulcerated Infantile Haemangioma of Buttock Successfully Treated With Topical Timolol , 2013, Journal of cutaneous and aesthetic surgery.

[3]  A. Izadpanah,et al.  Propranolol versus Corticosteroids in the Treatment of Infantile Hemangioma: A Systematic Review and Meta-Analysis , 2013, Plastic and reconstructive surgery.

[4]  G. Binenbaum,et al.  A Controlled Study of Topical 0.25% Timolol Maleate Gel for the Treatment of Cutaneous Infantile Capillary Hemangiomas , 2012, Ophthalmic plastic and reconstructive surgery.

[5]  K. Kunzi-Rapp,et al.  Topical Propranolol Therapy for Infantile Hemangiomas , 2012, Pediatric dermatology.

[6]  I. Frieden,et al.  Timolol Maleate 0.5% or 0.1% Gel‐Forming Solution for Infantile Hemangiomas: A Retrospective, Multicenter, Cohort Study , 2012, Pediatric dermatology.

[7]  K. Ezzedine,et al.  First report of topical timolol treatment in primarily ulcerated perineal haemangioma , 2011, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[8]  S. Prey,et al.  Infantile haemangioma: Part II. Risks, complications and treatment , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

[9]  S. Orlow,et al.  Abortive segmental perineal hemangioma. , 2011, Dermatology online journal.

[10]  M. Fakhry,et al.  Evaluation of intralesional propranolol for periocular capillary hemangioma. , 2011 .

[11]  L. S. Schultze Kool,et al.  Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls. , 2011, Journal of the American Academy of Dermatology.

[12]  S. Barbarot,et al.  Propranolol for treatment of ulcerated infantile hemangiomas. , 2011, Journal of the American Academy of Dermatology.

[13]  P. Langer,et al.  Topical timolol for periocular hemangioma: report of further study. , 2011, Archives of ophthalmology.

[14]  P. Hoeger,et al.  Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action , 2010, The British journal of dermatology.

[15]  E. Pope,et al.  Topical timolol gel for infantile hemangiomas: a pilot study. , 2010, Archives of dermatology.

[16]  Suqin Guo,et al.  Topical treatment for capillary hemangioma of the eyelid using beta-blocker solution. , 2010, Archives of ophthalmology.

[17]  Kristen E Holland,et al.  Infantile hemangioma. , 2016, Pediatric clinics of North America.

[18]  I. Frieden.  Addendum: Commentary on Becaplermin Gel (Regranex) for Hemangiomas , 2008, Pediatric dermatology.

[19]  T. Olah,et al.  Plasma timolol concentrations of timolol maleate: timolol gel-forming solution (TIMOPTIC-XE®) once daily versus timolol maleate ophthalmic solution twice daily , 2001, Documenta Ophthalmologica.

[20]  M. Colombo,et al.  Ulcerated hemangiomas: clinical characteristics and response to therapy. , 2001, Journal of the American Academy of Dermatology.

[21]  R. Geronemus,et al.  Guidelines of care for hemangiomas of infancy , 1997 .

[22]  R. Geronemus,et al.  Guidelines of care for hemangiomas of infancy. American Academy of Dermatology Guidelines/Outcomes Committee. , 1997, Journal of the American Academy of Dermatology.